PURPOSE: Traditional quality control materials used for monitoring the clinical laboratory test accuracy might be non-commutable with patient samples and may not detect systematic errors. The aim of this paper is to describe a method to monitor inter-instrument bias using result distributions that are independent of the control's commutability. DESIGN/METHODOLOGY/APPROACH: Serum calcium data collected within a laboratory network were assessed. A reference interval was calculated using a computerized, indirect Hoffmann's algorithm using all data across a laboratory network without excluding any results. Results outside the reference interval were considered as the zero-bias distribution. Three allowable bias levels were then calculated to determine the corresponding shift in abnormal results for each bias level in both directions from the zero-bias distribution. The observed result distributions in three laboratories within the network were compared for bias performance after one year of the reference interval study. FINDINGS: Performance levels for bias were: minimum allowable < 1.27 percent; desirable < 0.85 percent; and optimal < 0.42 percent. Zero bias result distribution above and below the reference interval for calcium was 3.92 percent and 2.53 percent respectively. All three laboratories performed within the desirable allowable bias level. ORIGINALITY/VALUE: Bias-monitoring process using patient result distributions allows managers to: assess systematic error between laboratory instruments; improve laboratory quality control; and strengthen patient risk management.
No takes yet. Share an insight, caveat, or question.
Katayev et al. (2014) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: